Showing articles from Stock Titan

Absci Teams Up with Owkin to Supercharge AI Drug Discovery in Cancer and Immunology

Strategic AI partnership combines Absci's drug creation platform with Owkin's predictive models to accelerate novel therapeutic development... 1 day ago

Stock Titan | 2025-01-11 12:06:04

Absci Secures $20M AMD Investment, Strategic AI Drug Discovery Partnership to Accelerate Innovation

AMD invests in Absci through PIPE deal, providing advanced Instinct accelerators to power AI-driven antibody design. 4 days ago

Stock Titan | 2025-01-08 12:06:04